Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA awards fast track designation to Indivior's RBP-6000 buprenorphine monthly depot

May 27, 2016

FDA approves Probuphine for opioid dependence

May 27, 2016

Cerecor awarded NIDA grant

April 12, 2016

XT-150 as a potential solution for opioid abuse crisis

April 4, 2016

Cleveland BioLabs updates progress of entolimod pre-EUA review

March 17, 2016

Narcan now available in U.S. for the treatment of opioid overdose

Feb. 26, 2016

FDA lifts clinical hold on Aeolus's AEOL-10150 in acute radiation syndrome

Feb. 23, 2016

FDA extends Probuphine NDA review date

Feb. 22, 2016

EMA grants orphan drug status for entolimod as a radiation countermeasure

Jan. 22, 2016

FDA approves Neulasta to treat radiation sickness

Jan. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...